Brief: Guard Therapeutics Granted FDA Fast Track Designation For Rmc-035

Disruptive Pharma AB (publ)

08/11/2022 07:43

Nov 8 (Reuters) - Guard Therapeutics International AB (publ)  GUARD.ST :
    * GUARD THERAPEUTICS GRANTED FDA FAST TRACK DESIGNATION FOR RMC-035
    * FDA GRANTED RMC-035 FAST TRACK DESIGNATION FOR REDUCING RISK OF AN IRREVERSIBLE LOSS OF
KIDNEY
FUNCTION

Source text for Eikon:  ID:nMFN4F6ts0 
Further company coverage:  GUARD.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))